Moderna’s Covid-19 vaccine does a slightly better job of preventing coronavirus-related hospitalizations and emergency department visits.
Swedish drugmaker Orphan Biovitrum (SOBI) has agreed to an $8 billion takeover bid from US private equity firm Advent International Singapore’s sovereign wealth fund GIC.
South Korea’s biggest producer of botulinum toxin, Hugel is concerned about its expansion now as Botox Company is sold.
Bayer AG is in talks to buy Vividion Therapeutics in a roughly $2 billion deal, enforcing new IPO plans for Vividion.
Sanofi’s CEO Paul Hudson is dead serious about mRNA technology and capabilities with a $3.2 billion acquisition offer to Translate Bio.
Tokyo Olympic Games 2021 face cancellation threat due to the rising number of Covid-19 cases, says organizing committee head.
Johnson & Johnson (J&J) announced Wednesday it is recalling five of its sunscreen products after some samples were found to contain low levels of Benzene, a chemical that c
The rise in new variants of the Coronavirus and poor access to vaccines in developing countries will derail the recovery of economies across the world, warn the finance ministers o
Flagship Pioneering, the bioplatform company, and the venture capital investor in Moderna, today announced that it had raised additional funding of $2.23 billion, which brings its